Neuro-ophthalmology of late-onset Tay-Sachs disease (LOTS)

Neurology

Volumn 63, Issue 10, 2004, Pages 1918-1926

  Rucker, J C ^a   Shapiro, B E ^a   Han, Y H ^b   Kumar, A N ^b   Garbutt, S ^c   Keller, E L ^c   Leigh, R J ^a,b,d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTERIOR HORN CELL; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BINOCULAR CONVERGENCE; CEREBELLUM; CLINICAL ARTICLE; COLOR VISION; CONTRAST SENSITIVITY; DISEASE DURATION; DYSMETRIA; EYE FUNDUS; EYE MOVEMENT; EYE TRACKING; FEMALE; GAZE; GM2 GANGLIOSIDOSIS; HUMAN; LATE ONSET TAY SACHS DISEASE; MALE; NEUROOPHTHALMOLOGY; PRIORITY JOURNAL; SACCADIC EYE MOVEMENT; SMOOTH PURSUIT EYE MOVEMENT; STEREOSCOPIC VISION; TAY SACHS DISEASE; VESTIBULOOCULAR REFLEX; VISUAL ACUITY; VISUAL FIELD;

EID: 8844254599     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000144275.76658.F4     Document Type: Article

References (50)

1. Kaback MM, Rimoin DL, O'Brien JS. Tay-Sachs disease: screening and prevention. New York: Liss. 1977.
2. Petersen GM, Rotter JI, Cantor RM, et al. The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin. Am J Hum Genet 1983;35:1258-1269.
3. Grebner EE, Tomczak J. Distribution of three alpha-chain beta-hexosaminidase A mutations among Tay-Sachs carriers. Am J Hum Genet 1991;48:604-607.
4. Jeyakumar M, Smith D, Eliott-Smith E, et al. An inducible mouse model of late onset Tay-Sachs disease. Neurobiol Dis 2002;10:201-210.
5. Andermann E, Scriver CR, Wolfe LS, et al. Genetic variants of Tay-Sachs disease and Sandhoffs disease in French-Canadians, juvenile Tay-Sachs disease in Lebanese Canadians, and a Tay-Sachs screening program in the French-Canadian population. In: Kaback MM, Rimoin DL, O'Brien JS, eds. Tay-Sachs disease: screening and prevention. New York: Liss, 1977:161-168.
6. Chern CJ, Beutler E, Kuhl W, et al. Characterization of heteropolymeric hexosaminidase A in human X mouse hybrid cells. Proc Natl Acad Sci USA 1976;73:3637-3640.
7. Myerowitz R, Costigan FC. The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase. J Bioll Chem 1988;263:18587-18589.
8. Triggs-Raine BL, Feigenbaum AS, Natowicz M, et al. Screening for carriers of Tay-Sachs disease among Ashkenzi Jews: a comparison of DNA-based and enzyme-based tests. N Engl J Med 1990;323:6-12.
9. Navon R, Proia RL. The mutation in Ashkenazi Jews with adult GM2 gangliosidoses, the adult form of Tay-Sachs disease. Science 1989;243:1471-1474.
10. Paw BH, Kaback MM, Neufeld EF. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase. Proc Natl Acad Sci USA 1989;86:2413-2417.
11. Navon R, Kolodny EH, Mitsumoto H, et al. Ashkenazi-Jewish and non-Jewish adult GM2 gangliosidosis patients share a common genetic defect. Am J Hum Genet 1990;46:817-821.
12. Brown CA, Mahuran DJ. Beta-hexosaminidase isozymes from cells co-transfected with alpha and beta cDNA constructs: analysis of the alpha subunit missense mutation associated with the adult form of Tay-Sachs disease. Am J Hum Genet 1993;53:497-508.
13. d'Azzo A, Proia RL, Kolodny EH, et al. Faulty association of alpha and beta-subunits in some forms of beta-hexosaminidase A deficiency. J Biol Chem 1984;259:11070-11074.
14. Specola N, Vanier MT, Goutieres F, et al. The juvenile and chronic forms of GM2 gangliosidosis: clinical and enzymatic heterogeneity. Neurology 1990;40:145-150.
15. Rapin I, Suzuki K, Suzuki K, Valsamis MP. Adult (chronic) GM2 gangliosidosis: atypical spinocerebellar degeneration in a Jewish sibship. Arch Neurol 1976;33:120-130.
16. Musarella MA, Raab EL, Rudolph SH. Oculomotor abnormalities in chronic GM2 gangliosidosis. J Pediatr Ophthalmol Strabismus 1982;19:80-88.
17. Hund E, Grau A, Fogel W, et al. Progressive cerebellar ataxia, proximal neurogenic weakness and ocular motor disturbances: hexosaminidase A deficiency with late clinical onset in four siblings. J Neurol Sci 1997;145:25-31.
18. Kolodny EH. The GM2 gangliosidoses. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RI, eds. The molecular and genetic basis of neurological disease. 2nd ed. Boston: Butterworth-Heinemann, 1997:473-490.
19. Navon R. Late-onset GM2 gangliosidosis and other hexosaminidase mutations among Jews. Adv Genet 2001;44:185-197.
20. Streifler JY, Gornish M, Hadar H, Gadoth N. Brain imaging in late-onset GM2 gangliosidosis. Neurology 1993;43:2055-2058.
21. Argov Z, Navon R. Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency. Ann Neurol 1984;16:14-20.
22. Willner JP, Grabowski GA, Gordon RE, et al. Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic, and biochemical studies of nine cases. Neurology 1981;31:787-798.
23. Harding AE, Young EP. Schon F. Adult onset supranuclear ophthalmoplegia, cerebellar ataxia, and neurogenic proximal muscle weakness in a brother and sister: another hexosaminidase A deficiency syndrome. J Neurol Neurosurg Psychiatry 1987;50:687-690.
24. Barnes D, Misra VP, Young EP. et al. An adult onset hexosaminidase A deficiency syndrome with sensory neuropathy and internuelear ophthalmoplegia. J Neurol Neurosurg Psychiatry 1991;54:1112-1113.
25. DeGasperi R, GamaSosa MA, Battistini S, et al. Late onset GM2 gangliosidosis: Ashkenazi Jewish family with an exon 5 mutation (Tyr180 → His) in the Hex A alpha-chain gene. Neurology 1996;47:547-552.
26. Leigh RJ, Zee DS. The neurology of eye movements. 3rd ed. New York: Oxford University Press, 1999.
27. Kaminski HJ, Leigh RJ, eds. The neurobiology of eye movements-from molecules to behavior. Ann NY Acad Sci 2002;956:1-615.
28. Leigh RJ, Kennard C. Using saccades as a research tool in the clinical neurosciences. Brain 2004;127:1-18.
29. Rucker JC, Shapiro BE, Han YH, Kumar AN, Garbutt S, Leigh RJ. Neuro-ophthalmology of late-onset Tay-Sachs disease. Neurology 2004;62(suppl)A63.
30. Garbutt S, Han Y, Kumar A, Harwood M, Harris C, Leigh R. Vertical optokinetic nystagmus and saccades in normal human subjects. Invest Ophthalmol Vis Sci 2003;44:3833-3841.
31. Ramat S, Somers JT, Das VE, Leigh RJ. Conjugate ocular oscillations during shifts of the direction and depth of visual fixation. Invest Ophthalmol Vis Sci 1999;40:1681-1686.
32. Garbutt S, Harwood M, Kumar A, Han Y, Leigh R. Evaluating small eye movements in patients with saccadic palsies. Ann NY Acad Soc 2003;1004:337-346.
33. Abel LA, Traccis S, Troost BT, Dell'Osso LD. Saccadic trajectories change with amplitude, not time. Neuro-ophthalmology 1987;7:309-314.
34. Han Y, Somers JT, Kim J-I, Kumar AN, Leigh RJ. Ocular responses to head rotation during mirror-viewing. J Neurophysiol 2001;86:2323-2329.
35. Kivlin JD, Sanborn GE, Myers GG. The cherry-red spot in Tay-Sachs and other storage diseases. Ann Neurol 1985;17:356-360.
36. Cogan DG, Kuwabara T, Kolodny E, Driscoll S. Gangliosidoses and the fetal retina. Ophthalmology 1984;91:508-512.
37. Horn AKE, Büttner-Ennever JA, Suzuki Y, Henn V. Histological identification of premotor neurons for horizontal saccades in monkey and man by parvalbumin immunostaining. J Comp Neurol 1997;359:350-363.
38. Horn AKE, Büttner-Ennever JA. Premotor neurons for vertical eye-movements in the rostral mesencephalon of monkey and man: the histological identification by parvalbumin immunostaining. J Comp Neurol 1998;392:413-427.
39. van Gisbergen JAM, Robinson DA, Gielen S. A quantitative analysis of generation of saccadic eye movements by burst neurons. J Neurophysiol 1981;45:417-442.
40. Büttner-Ennever JA, Cohen B, Pause M, Fries W. Raphe nucleus of pons containing omnipause neurons of the oculomotor system in the monkey, and its homologue in man. J Comp Neurol 1988;267:307-321.
41. Horn AKE, Büttner-Ennever JA, Wahle P, Reichenberger I. Neurotransmitter profile of saccadic omnipause neurons in nucleus raphe interpositus. J Neurosci 1994;14:2032-2046.
42. Demer JL. Pivotal role of orbital connective tissues in binocular alignment and strabismus. Invest Ophthalmol Vis Sci 2004;45:729-738.
43. Yoshida K, Iwamoto Y, Chimoto S, Shimazu H. Saccade-related inhibitory input to pontine omnipause neurons: an intracellular study in alert cats. J Neurophysiol 1999;82:1198-1208.
44. Keller EL, Missal M. Shared brainstem pathways for saccades and smooth-pursuit eye movements. Ann NY Acad Sci 2003;1004:29-39.
45. King, WM, Fuchs AF. Neuronal activity in the mesencephalon related to vertical eye movements. In: Baker R, Berthoz A, eds. Control of gaze by brain stem neurons. Amsterdam: Elsevier, 1977:319-326.
46. Keller EL. Control of saccadic eye movements by midline brain stem neurons. In: Baker R, Berthoz A, eds. Control of gaze by brain stem neurons. Amsterdam: Elsevier, 1977:327-336.
47. Keller EL, Ganghi NJ, Shieh JM. Endpoint accuracy in saccades interrupted by stimulation in the omnipause region in monkeys. Vis Neurosci 1996;13:1059-1067.
48. Quaia C, Lefevre P, Optican LM. Model of the control of saccades by superior colliculus and cerebellum. J Neurophysiol 1999;82:999-1018.
49. Thier P, Dicke PW, Haas R, Barash S. Encoding of movement time by populations of cerebellar Purkinje cells. Nature 2000;405:72-76.
50. Robinson FR, Straube A, Fuchs AF. Role of the caudal fastigial nucleus in saccade generation. II. Effects of muscimol inactivation J Neurophysiol 1993;70:1741-1758.